Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:Experimental Neoplasms
go back to main search page
Accession:DOID:9002170 term browser browse the term
Definition:Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
Synonyms:exact_synonym: Experimental Neoplasm
 primary_id: MESH:D009374
For additional species annotation, visit the Alliance of Genome Resources.



show annotations for term's descendants           Sort by:
 
Experimental Neoplasms term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G 1520401A03Rik RIKEN cDNA 1520401A03 gene ISO CTD Direct Evidence: marker/mechanism CTD PMID:34652879 NCBI chr17:23,923,582...23,945,299
Ensembl chr17:23,923,462...23,941,757
JBrowse link
G Abl1 c-abl oncogene 1, non-receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19878872 NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239
JBrowse link
G Ahr aryl-hydrocarbon receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:9496914 NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
JBrowse link
G AI480526 expressed sequence AI480526 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34561789 Ensembl chr 5:123,271,786...123,279,729 JBrowse link
G Arl6ip5 ADP-ribosylation factor-like 6 interacting protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29545876 NCBI chr 6:97,187,753...97,210,276
Ensembl chr 6:97,187,650...97,210,276
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator ISO CTD Direct Evidence: marker/mechanism CTD PMID:9496914 NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
JBrowse link
G Axl AXL receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:26206560 NCBI chr 7:25,455,925...25,488,502
Ensembl chr 7:25,456,698...25,488,130
JBrowse link
G Bcr BCR activator of RhoGEF and GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19878872 NCBI chr10:74,896,384...75,020,755
Ensembl chr10:74,896,424...75,020,753
JBrowse link
G Braf Braf transforming gene ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397
JBrowse link
G Bsg basigin ISO CTD Direct Evidence: marker/mechanism CTD PMID:21165561 NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803
JBrowse link
G Ccnd1 cyclin D1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Cdh1 cadherin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27224422 NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
JBrowse link
G Cdk4 cyclin-dependent kinase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
JBrowse link
G Ctcf CCCTC-binding factor ISO human breast cancer cells in mouse model RGD PMID:21896759 RGD:151356745 NCBI chr 8:106,351,135...106,409,554
Ensembl chr 8:106,363,200...106,409,554
JBrowse link
G Ddr1 discoidin domain receptor family, member 1 treatment ISO human cancer cells in mouse model RGD PMID:26719540 RGD:11520844 NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
JBrowse link
G Eno2 enolase 2, gamma neuronal ISO CTD Direct Evidence: marker/mechanism CTD PMID:22613180 NCBI chr 6:124,737,016...124,746,636
Ensembl chr 6:124,737,016...124,746,636
JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14612517 NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
JBrowse link
G Ergic3 ERGIC and golgi 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27588471 NCBI chr 2:155,849,948...155,860,199
Ensembl chr 2:155,849,965...155,860,199
JBrowse link
G Esrra estrogen related receptor, alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:34524571 NCBI chr19:6,888,345...6,899,416
Ensembl chr19:6,888,345...6,899,208
JBrowse link
G F2r coagulation factor II (thrombin) receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:17374729 NCBI chr13:95,738,288...95,754,974
Ensembl chr13:95,738,311...95,754,995
JBrowse link
G Hdac6 histone deacetylase 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34524571 NCBI chr  X:7,796,355...7,814,284
Ensembl chr  X:7,796,359...7,814,128
JBrowse link
G Hgf hepatocyte growth factor ISO CTD Direct Evidence: therapeutic CTD PMID:21273587 NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
JBrowse link
G Hif1a hypoxia inducible factor 1, alpha subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:28574600 NCBI chr12:73,948,098...73,994,328
Ensembl chr12:73,948,149...73,994,304
JBrowse link
G Hras Harvey rat sarcoma virus oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:3433577 PMID:11552296 PMID:26558449 NCBI chr 7:140,769,847...140,773,938
Ensembl chr 7:140,769,018...140,773,918
JBrowse link
G Hrh2 histamine receptor H2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:6224980 NCBI chr13:54,345,990...54,390,201
Ensembl chr13:54,346,148...54,390,199
JBrowse link
G Ifna interferon alpha EXP CTD Direct Evidence: therapeutic CTD PMID:1674182 PMID:2297754
G Ifnb1 interferon beta 1, fibroblast ISO CTD Direct Evidence: therapeutic CTD PMID:2297754 NCBI chr 4:88,440,262...88,441,031
Ensembl chr 4:88,440,262...88,441,011
JBrowse link
G Ifng interferon gamma ISO CTD Direct Evidence: therapeutic CTD PMID:15711825 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Il12a interleukin 12a ISO CTD Direct Evidence: therapeutic CTD PMID:17332360 NCBI chr 3:68,597,977...68,605,883
Ensembl chr 3:68,597,977...68,605,880
JBrowse link
G Il12b interleukin 12b ISO CTD Direct Evidence: therapeutic CTD PMID:17332360 NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
JBrowse link
G Il2 interleukin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:1949363 PMID:3495671 PMID:22306178 NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
JBrowse link
G Itgav integrin alpha V treatment ISO human cells in rat model RGD PMID:20841470 RGD:152998949 NCBI chr 2:83,551,625...83,637,261
Ensembl chr 2:83,554,741...83,637,260
JBrowse link
G Kif11 kinesin family member 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17974955 NCBI chr19:37,364,830...37,410,311
Ensembl chr19:37,364,851...37,410,307
JBrowse link
G Kras Kirsten rat sarcoma viral oncogene homolog ISO CTD Direct Evidence: marker/mechanism CTD PMID:9205081 PMID:10813127 PMID:21311774 PMID:25851810 PMID:26390243 NCBI chr 6:145,162,425...145,196,144
Ensembl chr 6:145,162,425...145,195,965
JBrowse link
G Ldha lactate dehydrogenase A ISO RGD PMID:11085542 RGD:1600281 NCBI chr 7:46,491,698...46,505,051
Ensembl chr 7:46,490,899...46,505,051
JBrowse link
G Lect2 leukocyte cell-derived chemotaxin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:30453282 NCBI chr13:56,676,772...56,696,373
Ensembl chr13:56,690,277...56,696,315
JBrowse link
G Mapk7 mitogen-activated protein kinase 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29507229 NCBI chr11:61,379,638...61,385,101
Ensembl chr11:61,379,638...61,385,232
JBrowse link
G Mir143 microRNA 143 ISO CTD Direct Evidence: therapeutic CTD PMID:28736328 PMID:31152816 NCBI chr18:61,782,267...61,782,329
Ensembl chr18:61,782,267...61,782,329
JBrowse link
G Mir323 microRNA 323 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,678,942...109,679,027
Ensembl chr12:109,678,942...109,679,027
JBrowse link
G Mir337 microRNA 337 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,552,223...109,552,319
Ensembl chr12:109,552,223...109,552,319
JBrowse link
G Mir34b microRNA 34b ISO CTD Direct Evidence: therapeutic CTD PMID:22113133 NCBI chr 9:51,014,862...51,014,945
Ensembl chr 9:51,014,862...51,014,945
JBrowse link
G Mir369 microRNA 369 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,709,852...109,709,930
Ensembl chr12:109,709,852...109,709,930
JBrowse link
G Mir370 microRNA 370 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,584,692...109,584,770
Ensembl chr12:109,584,692...109,584,770
JBrowse link
G Mir376a microRNA 376a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,690,215...109,690,282
Ensembl chr12:109,690,215...109,690,282
JBrowse link
G Mir376b microRNA 376b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,689,892...109,689,973
Ensembl chr12:109,689,892...109,689,973
JBrowse link
G Mir379 microRNA 379 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,675,494...109,675,559
Ensembl chr12:109,675,494...109,675,559
JBrowse link
G Mir381 microRNA 381 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,693,256...109,693,330
Ensembl chr12:109,693,256...109,693,330
JBrowse link
G Mir382 microRNA 382 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,700,205...109,700,280
Ensembl chr12:109,700,205...109,700,280
JBrowse link
G Mir431 microRNA 431 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,556,881...109,556,971
Ensembl chr12:109,556,881...109,556,971
JBrowse link
G Mir433 microRNA 433 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,558,149...109,558,272
Ensembl chr12:109,558,149...109,558,272
JBrowse link
G Mir485 microRNA 485 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,701,336...109,701,408
Ensembl chr12:109,701,336...109,701,408
JBrowse link
G Mir487b microRNA 487b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,693,767...109,693,848
Ensembl chr12:109,693,767...109,693,848
JBrowse link
G Mir495 microRNA 495 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,685,188...109,685,250
Ensembl chr12:109,685,188...109,685,250
JBrowse link
G Mir654 microRNA 654 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,689,652...109,689,735
Ensembl chr12:109,689,652...109,689,735
JBrowse link
G Mir758 microRNA 758 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,679,244...109,679,324
Ensembl chr12:109,679,244...109,679,324
JBrowse link
G Mir770 microRNA 770 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr12:109,530,126...109,530,219
Ensembl chr12:109,530,126...109,530,219
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:9496914 PMID:21034357 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
JBrowse link
G Nras neuroblastoma ras oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:9205081 NCBI chr 3:102,965,601...102,975,230
Ensembl chr 3:102,965,601...102,975,230
JBrowse link
G Parg poly (ADP-ribose) glycohydrolase ISO CTD Direct Evidence: therapeutic CTD PMID:33044785 NCBI chr14:31,923,900...32,020,671
Ensembl chr14:31,923,906...32,019,507
JBrowse link
G Pcna proliferating cell nuclear antigen ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
JBrowse link
G Polr1h RNA polymerase I subunit H ISO CTD Direct Evidence: marker/mechanism CTD PMID:16609701 NCBI chr17:37,265,250...37,269,417
Ensembl chr17:37,265,248...37,269,451
JBrowse link
G Prl prolactin treatment ISO RGD PMID:26983879 RGD:152177690 NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
JBrowse link
G Prnp prion protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:21265952 NCBI chr 2:131,751,848...131,780,356
Ensembl chr 2:131,751,848...131,780,349
JBrowse link
G Puf60 poly-U binding splicing factor 60 ISO CTD Direct Evidence: therapeutic CTD PMID:21435101 NCBI chr15:75,942,031...75,954,386
Ensembl chr15:75,942,031...75,952,773
JBrowse link
G Rb1 RB transcriptional corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27137931 NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr19:5,687,569...5,698,162
Ensembl chr19:5,687,511...5,698,158
JBrowse link
G Rictor RPTOR independent companion of MTOR, complex 2 disease_progression IMP RGD PMID:24244675 RGD:152995458 NCBI chr15:6,737,827...6,829,882
Ensembl chr15:6,737,860...6,829,882
JBrowse link
G Sparc secreted acidic cysteine rich glycoprotein ISO CTD Direct Evidence: therapeutic CTD PMID:20164124 NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
JBrowse link
G Spp1 secreted phosphoprotein 1 ISO CTD Direct Evidence: therapeutic CTD PMID:21852811 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
JBrowse link
G Stat3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29507229 NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
JBrowse link
G Stim1 stromal interaction molecule 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27863410 NCBI chr 7:101,909,279...102,086,525
Ensembl chr 7:101,917,013...102,086,526
JBrowse link
G Tnf tumor necrosis factor ISO CTD Direct Evidence: therapeutic CTD PMID:1674182 PMID:3361654 PMID:12627504 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Tnfsf10 tumor necrosis factor (ligand) superfamily, member 10 ISO CTD Direct Evidence: therapeutic CTD PMID:17767197 PMID:24345465 NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
JBrowse link
G Tob1 transducer of ErbB-2.1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12756225 NCBI chr11:94,100,668...94,106,321
Ensembl chr11:94,102,280...94,106,321
JBrowse link
G Trim47 tripartite motif-containing 47 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31981573 NCBI chr11:115,996,576...116,001,061
Ensembl chr11:115,996,578...116,018,036
JBrowse link
G Trp53 transformation related protein 53 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12756225 PMID:27137931 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Trp63 transformation related protein 63 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25739959 NCBI chr16:25,502,513...25,710,838
Ensembl chr16:25,502,513...25,710,852
JBrowse link
G Txn1 thioredoxin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28574600 NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
JBrowse link
G Uri1 URI1, prefoldin-like chaperone ISO CTD Direct Evidence: marker/mechanism CTD PMID:21397856 NCBI chr 7:37,659,417...37,722,989
Ensembl chr 7:37,659,417...37,722,976
JBrowse link
G Vegfa vascular endothelial growth factor A ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:20376344 PMID:20932960 PMID:28574600 NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
JBrowse link
Avian Sarcoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Rhob ras homolog family member B ISO RGD PMID:1710770 RGD:704375 NCBI chr12:8,547,661...8,550,009
Ensembl chr12:8,547,661...8,550,009
JBrowse link
Carcinoma, Lewis Lung term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G C3 complement component 3 treatment IEP RGD PMID:16947020 RGD:7401280 NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
JBrowse link
G Coq7 demethyl-Q 7 susceptibility IMP RGD PMID:23166727 RGD:10402105 NCBI chr 7:118,108,882...118,132,579
Ensembl chr 7:118,108,882...118,132,579
JBrowse link
G Csf1r colony stimulating factor 1 receptor ameliorates IMP mouse cell line in a mouse model RGD PMID:20008303 RGD:150524291 NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
JBrowse link
G Il18 interleukin 18 treatment IMP RGD PMID:16767432 RGD:8655941 NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
JBrowse link
G Il2 interleukin 2 treatment IDA RGD PMID:9399664 RGD:8663451 NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
JBrowse link
G Irak3 interleukin-1 receptor-associated kinase 3 ISO RGD PMID:21278795 RGD:36049796 NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
JBrowse link
G Jam3 junction adhesion molecule 3 IMP RGD PMID:15994945 RGD:7488936 NCBI chr 9:27,008,680...27,066,739
Ensembl chr 9:27,008,680...27,066,717
JBrowse link
G Lect2 leukocyte cell-derived chemotaxin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:30453282 NCBI chr13:56,676,772...56,696,373
Ensembl chr13:56,690,277...56,696,315
JBrowse link
G Mapk14 mitogen-activated protein kinase 14 ameliorates IMP mouse cell line in a mouse model RGD PMID:29907597 RGD:151665504 NCBI chr17:28,910,243...28,967,379
Ensembl chr17:28,910,303...28,967,380
JBrowse link
G Myd88 myeloid differentiation primary response gene 88 treatment IMP mouse cell line in a mouse model RGD PMID:26111447 RGD:150521531 NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
JBrowse link
G Txnrd1 thioredoxin reductase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16565519 NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
JBrowse link
Ehrlich tumor carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cd40 CD40 antigen treatment ISO RGD PMID:19269163 RGD:11352683 NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
JBrowse link
G Cd40lg CD40 ligand treatment ISO RGD PMID:19269163 RGD:11352683 NCBI chr  X:56,257,503...56,269,402
Ensembl chr  X:56,257,503...56,269,402
JBrowse link
G Ceacam20 CEA cell adhesion molecule 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34605108 NCBI chr 7:19,699,277...19,725,038
Ensembl chr 7:19,699,337...19,725,029
JBrowse link
Experimental Leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cbl Casitas B-lineage lymphoma treatment IMP RGD PMID:20890046 RGD:11038805 NCBI chr 9:44,054,273...44,145,556
Ensembl chr 9:44,054,273...44,145,346
JBrowse link
G Cbx7 chromobox 7 IMP RGD PMID:25434821 RGD:11352713 NCBI chr15:79,800,005...79,855,344
Ensembl chr15:79,800,008...79,855,320
JBrowse link
G Cdkn2a cyclin dependent kinase inhibitor 2A IMP RGD PMID:10090949 RGD:11251764 NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
JBrowse link
G Fgfr1 fibroblast growth factor receptor 1 treatment ISO RGD PMID:22781593 RGD:11352669 NCBI chr 8:26,008,775...26,065,734
Ensembl chr 8:26,003,670...26,065,734
JBrowse link
G Il1a interleukin 1 alpha treatment IDA RGD PMID:2117483 RGD:11051972 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
JBrowse link
G Lat2 linker for activation of T cells family, member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32587277 NCBI chr 5:134,628,957...134,648,637
Ensembl chr 5:134,628,876...134,643,879
JBrowse link
G Nras neuroblastoma ras oncogene induced ISO DNA:transversion mutation, loss of heterozygosity:cds: RGD PMID:9142215 RGD:11535063 NCBI chr 3:102,965,601...102,975,230
Ensembl chr 3:102,965,601...102,975,230
JBrowse link
G Ptpn11 protein tyrosine phosphatase, non-receptor type 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32417439 NCBI chr 5:121,268,596...121,329,460
Ensembl chr 5:121,268,596...121,329,460
JBrowse link
G Runx1 runt related transcription factor 1 treatment IMP RGD PMID:19236814 RGD:11251683 NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037
JBrowse link
Experimental Liver Neoplasms term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP-binding cassette, sub-family B (MDR/TAP), member 11 ISO RGD PMID:15853769 RGD:1598580 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,960
JBrowse link
G Abcb1b ATP-binding cassette, sub-family B (MDR/TAP), member 1B ISO RGD PMID:8104413 RGD:5684351 NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315
JBrowse link
G Adsl adenylosuccinate lyase ISO protein:increased activity:liver (rat) RGD PMID:2937404 RGD:1598766 NCBI chr15:80,832,691...80,855,148
Ensembl chr15:80,832,691...80,855,147
JBrowse link
G Afp alpha fetoprotein ISO CTD Direct Evidence: marker/mechanism CTD PMID:24012840 PMID:32961231 NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766
JBrowse link
G Agps alkylglycerone phosphate synthase ISO RGD PMID:7407223 RGD:1598794 NCBI chr 2:75,662,477...75,761,694
Ensembl chr 2:75,662,521...75,761,694
JBrowse link
G Alas2 aminolevulinic acid synthase 2, erythroid ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr  X:149,330,413...149,353,618
Ensembl chr  X:149,330,371...149,353,634
JBrowse link
G Apoa4 apolipoprotein A-IV ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
JBrowse link
G Apoc2 apolipoprotein C2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 7:19,405,504...19,411,866
Ensembl chr 7:19,405,504...19,411,866
JBrowse link
G Arid1a AT rich interactive domain 1A (SWI-like) disease_progression IMP RGD PMID:26569409 RGD:11344640 NCBI chr 4:133,406,319...133,484,682
Ensembl chr 4:133,406,319...133,484,080
JBrowse link
G Arrb2 arrestin, beta 2 ISO mRNA, protein:increased expression:liver (rat) RGD PMID:21167192 RGD:5509890 NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654
JBrowse link
G Atp7a ATPase, Cu++ transporting, alpha polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr  X:105,070,830...105,171,766
Ensembl chr  X:105,070,882...105,168,532
JBrowse link
G Atp7b ATPase, Cu++ transporting, beta polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr 8:22,482,799...22,550,632
Ensembl chr 8:22,482,801...22,550,321
JBrowse link
G Bak1 BCL2-antagonist/killer 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
JBrowse link
G Bbc3 BCL2 binding component 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 7:16,042,307...16,052,259
Ensembl chr 7:16,042,318...16,052,130
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:10426811 PMID:28100771 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Bcl2l1 BCL2-like 1 IMP
ISO
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:10426811 PMID:28100771 PMID:22414765 RGD:11353865 NCBI chr 2:152,600,652...152,675,723
Ensembl chr 2:152,622,588...152,673,648
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 ISO mRNA, protein:increased expression:liver RGD PMID:18246794 RGD:2293125 NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase ISO protein:increased activity:liver (rat) RGD PMID:13618893 RGD:5132586 NCBI chr 5:31,211,964...31,235,823
Ensembl chr 5:31,212,124...31,235,823
JBrowse link
G Car3 carbonic anhydrase 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 3:14,928,598...14,937,441
Ensembl chr 3:14,928,572...14,937,583
JBrowse link
G Ccl20 chemokine (C-C motif) ligand 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30603057 NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
JBrowse link
G Ccnb1 cyclin B1 ISO mRNA:increased expression:liver RGD PMID:17342310 RGD:2315991 NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
JBrowse link
G Ccnd1 cyclin D1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:28100771 PMID:17055752 RGD:2289139 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Ccndbp1 cyclin D-type binding-protein 1 ISO CTD Direct Evidence: therapeutic CTD PMID:16501603 NCBI chr 2:120,838,888...120,847,393
Ensembl chr 2:120,838,884...120,847,385
JBrowse link
G Ccng1 cyclin G1 IMP RGD PMID:27982046 RGD:151361200 NCBI chr11:40,639,379...40,646,155
Ensembl chr11:40,639,379...40,646,138
JBrowse link
G Ccng2 cyclin G2 IMP RGD PMID:27982046 RGD:151361200 NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090
JBrowse link
G Cd40lg CD40 ligand IMP RGD PMID:19035311 RGD:5491179 NCBI chr  X:56,257,503...56,269,402
Ensembl chr  X:56,257,503...56,269,402
JBrowse link
G Cd63 CD63 antigen ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr10:128,731,577...128,748,691
Ensembl chr10:128,736,858...128,748,691
JBrowse link
G Cdh1 cadherin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20118494 PMID:25319454 NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A (P21) ISO protein:decreased expression:liver: RGD PMID:8640740 RGD:8662309 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B disease_progression ISO mRNA:increased expression:liver (rat) RGD PMID:19533683 RGD:2315050 NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C (P57) disease_progression ISO protein:decreased expression:liver (rat)
protein:increased expression:liver (rat)
mRNA:increased expression:liver (rat)
RGD PMID:26606000 PMID:3965145 PMID:19533683 RGD:11354707, RGD:152998958, RGD:2315050 NCBI chr 7:143,012,076...143,014,802
Ensembl chr 7:143,012,076...143,014,787
JBrowse link
G Cops5 COP9 signalosome subunit 5 ISO protein:increased expression:liver (rat) RGD PMID:26606000 RGD:11354707 NCBI chr 1:10,094,825...10,108,384
Ensembl chr 1:10,094,826...10,108,393
JBrowse link
G Cp ceruloplasmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
JBrowse link
G Cps1 carbamoyl-phosphate synthetase 1 severity ISO mRNA:decreased expression:liver RGD PMID:3387993 RGD:2303406 NCBI chr 1:67,151,294...67,270,426
Ensembl chr 1:67,162,185...67,270,418
JBrowse link
G Ctnnb1 catenin (cadherin associated protein), beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11280770 PMID:20118494 PMID:21147764 NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
JBrowse link
G Cxcl9 chemokine (C-X-C motif) ligand 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 ISO mRNA:increased expression:liver RGD PMID:22687991 RGD:7296954 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11376689 PMID:21147764 NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
JBrowse link
G Cyp2a4 cytochrome P450, family 2, subfamily a, polypeptide 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 7:26,006,617...26,014,513
Ensembl chr 7:26,006,594...26,014,513
JBrowse link
G Cyp2c29 cytochrome P450, family 2, subfamily c, polypeptide 29 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr19:39,275,488...39,319,157
Ensembl chr19:39,257,849...39,319,157
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18056438 NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
JBrowse link
G Cyp2f2 cytochrome P450, family 2, subfamily f, polypeptide 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 7:26,819,380...26,833,085
Ensembl chr 7:26,819,334...26,833,085
JBrowse link
G Cyp3a16 cytochrome P450, family 3, subfamily a, polypeptide 16 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 5:145,373,119...145,406,550
Ensembl chr 5:145,373,119...145,406,533
JBrowse link
G Dhodh dihydroorotate dehydrogenase ISO protein:increased activity:liver (rat) RGD PMID:6331524 RGD:5132618 NCBI chr 8:110,319,876...110,335,330
Ensembl chr 8:110,317,975...110,335,305
JBrowse link
G Dtymk deoxythymidylate kinase ISO protein:increased activity:tumor (rat) RGD PMID:6244089 RGD:5133686 NCBI chr 1:93,720,298...93,730,246
Ensembl chr 1:93,720,298...93,729,656
JBrowse link
G Eno2 enolase 2, gamma neuronal ISO CTD Direct Evidence: marker/mechanism CTD PMID:2910524 NCBI chr 6:124,737,016...124,746,636
Ensembl chr 6:124,737,016...124,746,636
JBrowse link
G Ephx1 epoxide hydrolase 1, microsomal ISO RGD PMID:7260898 RGD:11252158 NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
JBrowse link
G F12 coagulation factor XII (Hageman factor) ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr13:55,565,771...55,574,617
Ensembl chr13:55,565,771...55,574,606
JBrowse link
G Fas Fas (TNF receptor superfamily member 6) ISO CTD Direct Evidence: marker/mechanism CTD PMID:30737368 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
JBrowse link
G Foxm1 forkhead box M1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15082532 NCBI chr 6:128,339,957...128,352,849
Ensembl chr 6:128,339,930...128,353,109
JBrowse link
G Gjb1 gap junction protein, beta 1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:18308698 PMID:1336494 RGD:7349398 NCBI chr  X:100,419,982...100,429,235
Ensembl chr  X:100,419,984...100,429,235
JBrowse link
G Gjb2 gap junction protein, beta 2 ISO RGD PMID:1336494 RGD:7349398 NCBI chr14:57,336,059...57,342,159
Ensembl chr14:57,336,057...57,342,159
JBrowse link
G Glul glutamate-ammonia ligase (glutamine synthetase) ISO CTD Direct Evidence: marker/mechanism CTD PMID:20118494 PMID:21147764 NCBI chr 1:153,775,675...153,785,469
Ensembl chr 1:153,775,690...153,785,469
JBrowse link
G Grp gastrin releasing peptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:2910524 NCBI chr18:66,005,826...66,019,670
Ensembl chr18:66,005,891...66,019,667
JBrowse link
G Gstp1 glutathione S-transferase, pi 1 ISO protein:increased expression:liver (rat)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:2563599 PMID:3124819 PMID:7585603 PMID:20188851 PMID:12016164 More... RGD:2317823, RGD:152998958 NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
JBrowse link
G H19 H19, imprinted maternally expressed transcript ISO DNA:hypomethylation:promoter
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:11420682 PMID:15352122 RGD:1342455 NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,131,886
JBrowse link
G Hat1 histone aminotransferase 1 ISO protein:increased expression:liver RGD PMID:17182829 RGD:2316578 NCBI chr 2:71,219,604...71,271,966
Ensembl chr 2:71,219,302...71,271,966
JBrowse link
G Hgf hepatocyte growth factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:11896611 NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
JBrowse link
G Hras Harvey rat sarcoma virus oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:7955063 PMID:20118494 PMID:21147764 PMID:27517622 NCBI chr 7:140,769,847...140,773,938
Ensembl chr 7:140,769,018...140,773,918
JBrowse link
G Htr2c 5-hydroxytryptamine (serotonin) receptor 2C ISO protein:increased expression:brainstem, cerebral cortex RGD PMID:17258772 RGD:1624998 NCBI chr  X:145,745,509...145,980,273
Ensembl chr  X:145,745,509...145,980,273
JBrowse link
G Igf2 insulin-like growth factor 2 treatment ISO RGD PMID:22425635 RGD:10402567 NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
JBrowse link
G Igf2r insulin-like growth factor 2 receptor ISO RGD PMID:15057872 PMID:9652747 RGD:2311623, RGD:2311630 NCBI chr17:12,901,293...12,988,593
Ensembl chr17:12,901,293...12,988,551
JBrowse link
G Ikbkg inhibitor of kappaB kinase gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:30737368 NCBI chr  X:73,436,883...73,498,013
Ensembl chr  X:73,436,896...73,497,460
JBrowse link
G Il6 interleukin 6 disease_progression ISO
IEP
CTD Direct Evidence: marker/mechanism
protein:increased expression:blood serum (mouse)
CTD
RGD
PMID:26297436 PMID:26569409 RGD:11344640 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Insr insulin receptor disease_progression ISO associated with Diabetes Mellitus, Experimental;protein:increased expression:cytoplasm,liver (rat) RGD PMID:15520221 RGD:2306052 NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617
JBrowse link
G Jak2 Janus kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
JBrowse link
G Kat6a K(lysine) acetyltransferase 6A ISO protein:increased expression:liver (rat) RGD PMID:17083329 RGD:2312274 NCBI chr 8:23,349,458...23,433,275
Ensembl chr 8:23,349,551...23,433,275
JBrowse link
G Kdr kinase insert domain protein receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr 5:76,093,487...76,139,885
Ensembl chr 5:76,093,487...76,139,118
JBrowse link
G Kras Kirsten rat sarcoma viral oncogene homolog disease_progression ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver (rat)
CTD
RGD
PMID:8603461 PMID:19533683 RGD:2315050 NCBI chr 6:145,162,425...145,196,144
Ensembl chr 6:145,162,425...145,195,965
JBrowse link
G Map2k1 mitogen-activated protein kinase kinase 1 ISO associated with Diabetes Mellitus, Experimental;protein:increased expression:liver RGD PMID:15520221 RGD:2306052 NCBI chr 9:64,093,051...64,160,887
Ensembl chr 9:64,093,052...64,160,913
JBrowse link
G Mapk1 mitogen-activated protein kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
JBrowse link
G Mapk3 mitogen-activated protein kinase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
JBrowse link
G Met met proto-oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
JBrowse link
G Mfge8 milk fat globule EGF and factor V/VIII domain containing ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 7:78,783,516...78,798,808
Ensembl chr 7:78,783,516...78,798,808
JBrowse link
G Mir10a microRNA 10a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr11:96,207,991...96,208,100
Ensembl chr11:96,207,991...96,208,100
JBrowse link
G Mir125a microRNA 125a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr17:18,051,074...18,051,141
Ensembl chr17:18,051,074...18,051,141
JBrowse link
G Mir145a microRNA 145a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr18:61,780,896...61,780,965
Ensembl chr18:61,780,896...61,780,965
JBrowse link
G Mir151 microRNA 151 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr15:73,126,664...73,126,731
Ensembl chr15:73,126,664...73,126,731
JBrowse link
G Mir18 microRNA 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr14:115,281,283...115,281,378
Ensembl chr14:115,281,283...115,281,378
JBrowse link
G Mir181c microRNA 181c ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 8:84,905,502...84,905,590
Ensembl chr 8:84,905,502...84,905,590
JBrowse link
G Mir181d microRNA 181d ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 8:84,905,345...84,905,416
Ensembl chr 8:84,905,345...84,905,416
JBrowse link
G Mir183 microRNA 183 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:30,169,667...30,169,736
Ensembl chr 6:30,169,667...30,169,736
JBrowse link
G Mir186 microRNA 186 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 3:157,249,916...157,249,986
Ensembl chr 3:157,249,916...157,249,986
JBrowse link
G Mir195a microRNA 195a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr11:70,125,868...70,125,961
Ensembl chr11:70,125,868...70,125,961
JBrowse link
G Mir196b microRNA 196b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:52,207,061...52,207,145
Ensembl chr 6:52,207,061...52,207,145
JBrowse link
G Mir200b microRNA 200b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 4:156,140,138...156,140,207
Ensembl chr 4:156,140,138...156,140,207
JBrowse link
G Mir206 microRNA 206 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:20,749,234...20,749,306
Ensembl chr 1:20,749,234...20,749,306
JBrowse link
G Mir207 microRNA 207 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 4:40,722,917...40,722,995
Ensembl chr 4:40,722,917...40,722,995
JBrowse link
G Mir212 microRNA 212 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr11:75,064,214...75,064,304
Ensembl chr11:75,064,214...75,064,304
JBrowse link
G Mir221 microRNA 221 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:19,012,533...19,012,627
Ensembl chr  X:19,012,533...19,012,627
JBrowse link
G Mir26a-1 microRNA 26a-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 9:118,860,864...118,860,953
Ensembl chr 9:118,860,864...118,860,953
JBrowse link
G Mir26b microRNA 26b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:74,433,469...74,433,553
Ensembl chr 1:74,433,469...74,433,553
JBrowse link
G Mir292 microRNA 292 EXP
ISO
CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 7:3,267,863...3,267,944
Ensembl chr 7:3,267,863...3,267,944
JBrowse link
G Mir301 microRNA 301 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr11:87,003,830...87,003,915
Ensembl chr11:87,003,830...87,003,915
JBrowse link
G Mir30a microRNA 30a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:23,311,350...23,311,420
Ensembl chr 1:23,311,350...23,311,420
JBrowse link
G Mir30b microRNA 30b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr15:68,209,264...68,209,359
Ensembl chr15:68,209,264...68,209,359
JBrowse link
G Mir30d microRNA 30d ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr15:68,213,057...68,213,138
Ensembl chr15:68,213,057...68,213,138
JBrowse link
G Mir30e microRNA 30e ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 4:120,629,803...120,629,894
Ensembl chr 4:120,629,803...120,629,894
JBrowse link
G Mir324 microRNA 324 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr11:69,902,869...69,902,957
Ensembl chr11:69,902,869...69,902,957
JBrowse link
G Mir331 microRNA 331 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr10:93,799,630...93,799,725
Ensembl chr10:93,799,630...93,799,725
JBrowse link
G Mir335 microRNA 335 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:30,741,298...30,741,395
Ensembl chr 6:30,741,298...30,741,395
JBrowse link
G Mir338 microRNA 338 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr11:119,905,591...119,905,688
Ensembl chr11:119,905,591...119,905,688
JBrowse link
G Mir339 microRNA 339 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 5:139,355,405...139,355,500
Ensembl chr 5:139,355,405...139,355,500
JBrowse link
G Mir340 microRNA 340 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr11:49,960,529...49,960,626
Ensembl chr11:49,960,529...49,960,626
JBrowse link
G Mir34a microRNA 34a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 4:150,152,911...150,153,012
Ensembl chr 4:150,152,911...150,153,012
JBrowse link
G Mir350 microRNA 350 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:176,599,891...176,599,989
Ensembl chr 1:176,599,891...176,599,989
JBrowse link
G Mir383 microRNA 383 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 8:38,719,287...38,719,356
Ensembl chr 8:38,719,287...38,719,356
JBrowse link
G Mir409 microRNA 409 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr12:109,709,592...109,709,670
Ensembl chr12:109,709,592...109,709,670
JBrowse link
G Mir429 microRNA 429 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 4:156,138,362...156,138,444
Ensembl chr 4:156,138,362...156,138,444
JBrowse link
G Mir483 microRNA 483 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 7:142,208,661...142,208,733
Ensembl chr 7:142,208,661...142,208,733
JBrowse link
G Mir505 microRNA 505 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:59,439,649...59,439,738
Ensembl chr  X:59,439,649...59,439,738
JBrowse link
G Mir539 microRNA 539 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr12:109,694,563...109,694,636
Ensembl chr12:109,694,563...109,694,636
JBrowse link
G Mir598 microRNA 598 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr14:63,964,638...63,964,716
Ensembl chr14:63,964,638...63,964,716
JBrowse link
G Mir652 microRNA 652 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:141,521,996...141,522,093
Ensembl chr  X:141,521,996...141,522,093
JBrowse link
G Mir671 microRNA 671 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 5:24,797,112...24,797,209
Ensembl chr 5:24,797,112...24,797,209
JBrowse link
G Mir708 microRNA 708 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 7:95,898,631...95,898,739
Ensembl chr 7:95,898,631...95,898,739
JBrowse link
G Mir760 microRNA 760 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 3:122,087,234...122,087,352
Ensembl chr 3:122,087,234...122,087,352
JBrowse link
G Mir872 microRNA 872 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 4:94,553,394...94,553,474
Ensembl chr 4:94,553,394...94,553,474
JBrowse link
G Mir92b microRNA 92b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 3:89,134,423...89,134,505
Ensembl chr 3:89,134,423...89,134,505
JBrowse link
G Mir98 microRNA 98 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:150,696,210...150,696,317
Ensembl chr  X:150,696,210...150,696,317
JBrowse link
G Mir99b microRNA 99b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr17:18,050,450...18,050,519
Ensembl chr17:18,050,450...18,050,519
JBrowse link
G Mirlet7b microRNA let7b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr15:85,591,520...85,591,604
Ensembl chr15:85,591,520...85,591,604
JBrowse link
G Mirlet7d microRNA let7d ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr13:48,689,488...48,689,590
Ensembl chr13:48,689,488...48,689,590
JBrowse link
G Mirlet7e microRNA let7e ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr17:18,050,614...18,050,706
Ensembl chr17:18,050,614...18,050,706
JBrowse link
G Mirlet7i microRNA let7i ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr10:122,821,545...122,821,629
Ensembl chr10:122,821,545...122,821,629
JBrowse link
G Mmp2 matrix metallopeptidase 2 ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression, increased activity:liver
CTD
RGD
PMID:30603057 PMID:19528495 PMID:19539802 RGD:2325736, RGD:2325734 NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
JBrowse link
G Mmp9 matrix metallopeptidase 9 ISO mRNA, protein:increased expression, increased activity:liver RGD PMID:19528495 PMID:19539802 RGD:2325736, RGD:2325734 NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
JBrowse link
G Mpeg1 macrophage expressed gene 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr19:12,438,134...12,442,649
Ensembl chr19:12,438,143...12,442,647
JBrowse link
G Myc myelocytomatosis oncogene ISO mRNA:increased expression:liver (rat)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:9079223 PMID:11280770 PMID:18560566 PMID:3335218 RGD:10059623 NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
JBrowse link
G Nos2 nitric oxide synthase 2, inducible ISO protein:increased expression:liver RGD PMID:10383909 RGD:2325277 NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
JBrowse link
G Notch1 notch 1 ISO protein:increased expression:liver RGD PMID:18942116 RGD:2325310 NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 ISO mRNA, protein:increased expression:liver (rat) RGD PMID:27867096 RGD:13442478 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 susceptibility IMP RGD PMID:17283114 RGD:14701032 NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17172636 PMID:24769335 PMID:25656644 NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
JBrowse link
G Nras neuroblastoma ras oncogene ISO human gene in mouse model RGD PMID:16286660 RGD:14975105 NCBI chr 3:102,965,601...102,975,230
Ensembl chr 3:102,965,601...102,975,230
JBrowse link
G Pemt phosphatidylethanolamine N-methyltransferase ISO protein:decreased expression:liver RGD PMID:7929120 RGD:1642378 NCBI chr11:59,861,440...59,937,394
Ensembl chr11:59,861,440...59,937,315
JBrowse link
G Plcl1 phospholipase C-like 1 disease_progression ISO mRNA:increased expression:liver (rat) RGD PMID:19533683 RGD:2315050 NCBI chr 1:55,442,722...55,793,444
Ensembl chr 1:55,445,080...55,793,444
JBrowse link
G Pml promyelocytic leukemia ISO CTD Direct Evidence: therapeutic CTD PMID:20377131 NCBI chr 9:58,124,462...58,157,077
Ensembl chr 9:58,125,359...58,157,069
JBrowse link
G Ppat phosphoribosyl pyrophosphate amidotransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:761203 NCBI chr 5:77,061,096...77,099,425
Ensembl chr 5:77,061,096...77,099,425
JBrowse link
G Ppp2ca protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform ISO mRNA:increased expression:liver (rat) RGD PMID:2562181 RGD:8693574 NCBI chr11:51,989,651...52,013,576
Ensembl chr11:51,989,508...52,018,605
JBrowse link
G Prdx1 peroxiredoxin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27517622 NCBI chr 4:116,542,796...116,557,197
Ensembl chr 4:116,542,741...116,558,019
JBrowse link
G Ptgr1 prostaglandin reductase 1 ISO protein:increased expression:liver RGD PMID:24853774 RGD:14401713 NCBI chr 4:58,965,590...58,987,131
Ensembl chr 4:58,965,439...58,987,119
JBrowse link
G Rad51 RAD51 recombinase ISO protein:decreased expression:liver RGD PMID:17219426 RGD:2292638 NCBI chr 2:118,943,295...118,966,554
Ensembl chr 2:118,943,274...118,977,926
JBrowse link
G Rb1 RB transcriptional corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17854601 NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
JBrowse link
G Rbmy RNA binding motif protein, Y chromosome EXP CTD Direct Evidence: marker/mechanism CTD PMID:22073224 NCBI chr  Y:2,830,680...2,841,858
Ensembl chr  Y:2,830,680...2,841,854
JBrowse link
G Rgn regucalcin ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr  X:20,416,005...20,428,328
Ensembl chr  X:20,416,026...20,428,328
JBrowse link
G Rida reactive intermediate imine deaminase A homolog ISO protein:increased expression:liver (rat) RGD PMID:12939504 RGD:9685719 NCBI chr15:34,484,168...34,495,392
Ensembl chr15:34,484,167...34,495,401
JBrowse link
G Rras2 related RAS viral (r-ras) oncogene 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147764 NCBI chr 7:113,646,017...113,717,016
Ensembl chr 7:113,646,017...113,717,016
JBrowse link
G Rrm1 ribonucleotide reductase M1 ISO RGD PMID:15224347 RGD:2316863 NCBI chr 7:102,090,902...102,118,978
Ensembl chr 7:102,090,902...102,118,978
JBrowse link
G Rxra retinoid X receptor alpha ISO mRNA, protein:decreased expression:liver RGD PMID:17786350 RGD:1643105 NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
JBrowse link
G Slc31a1 solute carrier family 31, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr 4:62,278,821...62,310,006
Ensembl chr 4:62,278,964...62,310,006
JBrowse link
G Slc7a5 solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 ISO mRNA:increased expression:liver RGD PMID:17498859 RGD:151357003 NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
JBrowse link
G Socs1 suppressor of cytokine signaling 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15197228 NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
JBrowse link
G Sox4 SRY (sex determining region Y)-box 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147764 NCBI chr13:29,132,902...29,137,682
Ensembl chr13:29,132,902...29,137,696
JBrowse link
G Spp1 secreted phosphoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
JBrowse link
G Sqle squalene epoxidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr15:59,186,941...59,203,042
Ensembl chr15:59,186,926...59,203,041
JBrowse link
G Stat3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26297436 PMID:28100771 NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
JBrowse link
G Tek TEK receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr 4:94,627,322...94,763,213
Ensembl chr 4:94,627,526...94,763,213
JBrowse link
G Tgfa transforming growth factor alpha ISO protein:increased expression:liver
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:9079223 PMID:16734725 RGD:2317490 NCBI chr 6:86,172,020...86,252,726
Ensembl chr 6:86,172,205...86,252,701
JBrowse link
G Tgfb1 transforming growth factor, beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
JBrowse link
G Tk1 thymidine kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr11:117,706,345...117,716,913
Ensembl chr11:117,706,352...117,716,918
JBrowse link
G Tnf tumor necrosis factor disease_progression
treatment
ISO
IEP
CTD Direct Evidence: marker/mechanism
protein:increased expression:blood serum (mouse)
Morris hepatoma
CTD
RGD
PMID:28100771 PMID:26569409 PMID:9063767 RGD:11344640, RGD:14696818 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Trp53 transformation related protein 53 ISO
EXP
CTD Direct Evidence: marker/mechanism CTD PMID:10626228 PMID:28100771 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Tsc22d1 TSC22 domain family, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15833021 PMID:17533171 NCBI chr14:76,652,401...76,745,205
Ensembl chr14:76,652,401...76,745,205
JBrowse link
G Vim vimentin ISO RGD PMID:19199359 RGD:6480440 NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
JBrowse link
G Xdh xanthine dehydrogenase ISO protein:decreased expression:liver RGD PMID:3460692 RGD:13210515 NCBI chr17:74,190,890...74,257,369
Ensembl chr17:74,190,890...74,257,191
JBrowse link
Experimental Melanoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acss1 acyl-CoA synthetase short-chain family member 1 treatment ISO RGD PMID:27539851 RGD:13831304 NCBI chr 2:150,460,031...150,510,160
Ensembl chr 2:150,460,025...150,510,420
JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 treatment ISO RGD PMID:27539851 RGD:13831304 NCBI chr 2:155,359,963...155,404,663
Ensembl chr 2:155,359,868...155,427,644
JBrowse link
G Antxr1 anthrax toxin receptor 1 treatment IMP
ISO
RGD PMID:19622764 PMID:19609240 RGD:9684925, RGD:9684939 NCBI chr 6:87,110,835...87,312,757
Ensembl chr 6:87,110,835...87,312,803
JBrowse link
G Braf Braf transforming gene ISO CTD Direct Evidence: marker/mechanism CTD PMID:29179997 PMID:29438700 NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397
JBrowse link
G Calr calreticulin ISO CTD Direct Evidence: therapeutic CTD PMID:16388313 NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
JBrowse link
G Ccl20 chemokine (C-C motif) ligand 20 treatment IDA RGD PMID:14500387 RGD:7483600 NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
JBrowse link
G Ctla4 cytotoxic T-lymphocyte-associated protein 4 treatment ISO RGD PMID:24041689 RGD:7411680 NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
JBrowse link
G Egr1 early growth response 1 IEP mRNA, protein:increased expression:salivary gland (mouse) RGD PMID:19517020 RGD:5131885 NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
JBrowse link
G Esr2 estrogen receptor 2 (beta) severity IMP RGD PMID:20354658 RGD:8694122 NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
JBrowse link
G Hgf hepatocyte growth factor IMP RGD PMID:9823327 RGD:8548620 NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
JBrowse link
G Ifnb1 interferon beta 1, fibroblast ISO CTD Direct Evidence: therapeutic CTD PMID:16417267 NCBI chr 4:88,440,262...88,441,031
Ensembl chr 4:88,440,262...88,441,011
JBrowse link
G Ikbkb inhibitor of kappaB kinase beta ISO RGD PMID:19276165 RGD:7495758 NCBI chr 8:23,149,221...23,196,605
Ensembl chr 8:23,149,228...23,196,605
JBrowse link
G Il18 interleukin 18 treatment IMP RGD PMID:12230493 PMID:17411412 RGD:8655870, RGD:8655901 NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
JBrowse link
G Il1a interleukin 1 alpha treatment IDA RGD PMID:8061895 RGD:7794735 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
JBrowse link
G Il1b interleukin 1 beta ISO RGD PMID:1966551 RGD:7401226 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il2 interleukin 2 ISO RGD PMID:11884028 RGD:8662950 NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
JBrowse link
G Kdm1a lysine (K)-specific demethylase 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:29438700 NCBI chr 4:136,277,844...136,330,127
Ensembl chr 4:136,277,851...136,330,034
JBrowse link
G Kdm4c lysine (K)-specific demethylase 4C ISO CTD Direct Evidence: marker/mechanism CTD PMID:29438700 NCBI chr 4:74,160,734...74,324,101
Ensembl chr 4:74,160,734...74,324,097
JBrowse link
G Mc1r melanocortin 1 receptor IAGP RGD PMID:20126537 RGD:5687319 NCBI chr 8:124,133,821...124,137,483
Ensembl chr 8:124,133,846...124,137,483
JBrowse link
G Pdcd1 programmed cell death 1 treatment IMP RGD PMID:19208793 RGD:9589070 NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
JBrowse link
G Pten phosphatase and tensin homolog ISO CTD Direct Evidence: marker/mechanism CTD PMID:29179997 NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
JBrowse link
G Pxn paxillin ISO CTD Direct Evidence: marker/mechanism CTD PMID:18492274 NCBI chr 5:115,630,153...115,694,046
Ensembl chr 5:115,644,735...115,694,046
JBrowse link
G Tert telomerase reverse transcriptase treatment IMP RGD PMID:19903903 RGD:11038656 NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
JBrowse link
Experimental Sarcoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Agps alkylglycerone phosphate synthase ISO RGD PMID:7407223 RGD:1598794 NCBI chr 2:75,662,477...75,761,694
Ensembl chr 2:75,662,521...75,761,694
JBrowse link
G Alb albumin IEP mRNA,protein:decreased expression:liver,serum: RGD PMID:1900492 RGD:11035284 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Epo erythropoietin ISO CTD Direct Evidence: therapeutic CTD PMID:9743294 NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
JBrowse link
G Ifng interferon gamma treatment IAGP RGD PMID:2119881 RGD:10755752 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Kras Kirsten rat sarcoma viral oncogene homolog ISO A to T transversion; Gln to His substitution RGD PMID:11295286 RGD:1598680 NCBI chr 6:145,162,425...145,196,144
Ensembl chr 6:145,162,425...145,195,965
JBrowse link
G Nras neuroblastoma ras oncogene ISO DNA:transversion:exon p.Q61L (human) RGD PMID:11295286 RGD:1598680 NCBI chr 3:102,965,601...102,975,230
Ensembl chr 3:102,965,601...102,975,230
JBrowse link
G Slc6a14 solute carrier family 6 (neurotransmitter transporter), member 14 ISO mRNA, protein:increased expression:brush border epithelial cell RGD PMID:17006743 RGD:1625275 NCBI chr  X:21,581,139...21,608,597
Ensembl chr  X:21,581,135...21,608,594
JBrowse link
Mammary Neoplasms, Experimental term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP-binding cassette, sub-family B (MDR/TAP), member 1A IEP RGD PMID:19654309 RGD:2315553 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Abcb1b ATP-binding cassette, sub-family B (MDR/TAP), member 1B IEP
EXP
CTD Direct Evidence: therapeutic CTD
RGD
PMID:14633655 PMID:19654309 RGD:2315553 NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315
JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 (Junior blood group) ISO CTD Direct Evidence: therapeutic CTD PMID:22767648 NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 8:46,924,074...46,989,088
Ensembl chr 8:46,924,074...46,989,088
JBrowse link
G Actb actin, beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509
JBrowse link
G Actg1 actin, gamma, cytoplasmic 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr11:120,236,513...120,239,321
Ensembl chr11:120,236,516...120,239,368
JBrowse link
G Actn4 actinin alpha 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 7:28,592,673...28,661,799
Ensembl chr 7:28,592,673...28,661,765
JBrowse link
G Adcy5 adenylate cyclase 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr16:34,974,863...35,126,113
Ensembl chr16:34,975,247...35,126,108
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing disease_progression
treatment
IMP
ISO
RGD PMID:19447866 PMID:22246620 RGD:8694414, RGD:8694468 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Afp alpha fetoprotein ISO CTD Direct Evidence: therapeutic CTD PMID:16322315 NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766
JBrowse link
G Agt angiotensinogen (serpin peptidase inhibitor, clade A, member 8) treatment IDA RGD PMID:20837666 RGD:5129167 NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
JBrowse link
G Agtr1a angiotensin II receptor, type 1a ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:8389152 PMID:18421211 RGD:2292665 NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
JBrowse link
G Agtr2 angiotensin II receptor, type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:8389152 NCBI chr  X:21,350,863...21,355,072
Ensembl chr  X:21,350,783...21,355,403
JBrowse link
G Akt1 thymoma viral proto-oncogene 1 IAGP RGD PMID:17210696 RGD:2315600 NCBI chr12:112,620,255...112,641,318
Ensembl chr12:112,620,255...112,641,318
JBrowse link
G Akt2 thymoma viral proto-oncogene 2 IAGP RGD PMID:17210696 RGD:2315600 NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251
JBrowse link
G Alcam activated leukocyte cell adhesion molecule ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr16:52,069,359...52,273,444
Ensembl chr16:52,069,359...52,274,437
JBrowse link
G Alox5ap arachidonate 5-lipoxygenase activating protein ISO mRNA:increased expression:mammary gland tumor (rat) RGD PMID:18959458 RGD:2313895 NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
JBrowse link
G Antxr1 anthrax toxin receptor 1 disease_progression ISO RGD PMID:22085271 RGD:9684855 NCBI chr 6:87,110,835...87,312,757
Ensembl chr 6:87,110,835...87,312,803
JBrowse link
G Anxa1 annexin A1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:12376462 PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
JBrowse link
G Anxa4 annexin A4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 6:86,713,822...86,770,616
Ensembl chr 6:86,713,822...86,770,566
JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 ISO RGD PMID:14973070 RGD:2325748 NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
JBrowse link
G Apoe apolipoprotein E IMP RGD PMID:22469977 RGD:7771597 NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
JBrowse link
G Aqp1 aquaporin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540
JBrowse link
G Ar androgen receptor ISO RGD PMID:12150826 RGD:6482679 NCBI chr  X:97,192,363...97,366,824
Ensembl chr  X:97,192,375...97,366,821
JBrowse link
G Areg amphiregulin IEP
ISO
protein:increased expression:mammary gland
mRNA:increased expression:mammary gland
RGD PMID:10225449 PMID:18421211 RGD:2292663, RGD:2292665 NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291
JBrowse link
G Arhgap5 Rho GTPase activating protein 5 disease_progression ISO
IMP
mRNA:increased expression:mammary gland RGD PMID:10939588 PMID:19703301 RGD:2316183, RGD:126848766 NCBI chr12:52,550,546...52,618,761
Ensembl chr12:52,550,755...52,618,758
JBrowse link
G Atpif1 ATPase inhibitory factor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 4:132,257,866...132,262,784
Ensembl chr 4:132,257,866...132,260,970
JBrowse link
G Aurka aurora kinase A ISO CTD Direct Evidence: marker/mechanism CTD PMID:12124350 NCBI chr 2:172,198,110...172,212,820
Ensembl chr 2:172,198,110...172,212,455
JBrowse link
G Bad BCL2-associated agonist of cell death treatment
severity
ISO RGD PMID:23404339 PMID:20732338 RGD:10053670, RGD:10053708 NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
JBrowse link
G Bak1 BCL2-antagonist/killer 1 IMP RGD PMID:19222350 RGD:2315700 NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
JBrowse link
G Bard1 BRCA1 associated RING domain 1 IMP RGD PMID:18443292 RGD:2293149 NCBI chr 1:71,066,690...71,142,300
Ensembl chr 1:71,066,657...71,142,305
JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr15:25,363,363...25,413,850
Ensembl chr15:25,363,363...25,413,850
JBrowse link
G Bax BCL2-associated X protein treatment
severity
ISO RGD PMID:23404339 PMID:20732338 RGD:10053670, RGD:10053708 NCBI chr 7:45,111,119...45,116,344
Ensembl chr 7:45,111,121...45,116,322
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 treatment ISO RGD PMID:23404339 PMID:22668016 RGD:10053670, RGD:10054128 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Bcl2l1 BCL2-like 1 treatment ISO RGD PMID:23404339 RGD:10053670 NCBI chr 2:152,600,652...152,675,723
Ensembl chr 2:152,622,588...152,673,648
JBrowse link
G Brca1 breast cancer 1, early onset susceptibility ISO
IAGP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:12203372 PMID:22767648 PMID:12203372 PMID:18443292 PMID:17505536 RGD:1599502, RGD:2293149, RGD:2293155 NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781
JBrowse link
G Bst2 bone marrow stromal cell antigen 2 disease_progression IEP
IMP
RGD PMID:23806386 PMID:23806386 RGD:14398495, RGD:14398495 NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100
JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase disease_progression ISO protein:increased expression:mammary gland RGD PMID:6030068 RGD:2303540 NCBI chr 5:31,211,964...31,235,823
Ensembl chr 5:31,212,124...31,235,823
JBrowse link
G Capzb capping actin protein of muscle Z-line subunit beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 4:138,920,210...139,019,131
Ensembl chr 4:138,920,210...139,019,129
JBrowse link
G Car9 carbonic anhydrase 9 ISO RGD PMID:17280655 RGD:2293194 NCBI chr 4:43,507,026...43,513,729
Ensembl chr 4:43,506,966...43,513,729
JBrowse link
G Cask calcium/calmodulin-dependent serine protein kinase (MAGUK family) ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr  X:13,383,319...13,713,020
Ensembl chr  X:13,383,319...13,717,606
JBrowse link
G Casp1 caspase 1 treatment IMP RGD PMID:10557324 RGD:2315886 NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
JBrowse link
G Casp3 caspase 3 treatment
severity
ISO RGD PMID:23404339 PMID:26699876 PMID:20732338 RGD:10053670, RGD:13782283, RGD:10053708 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Casp7 caspase 7 treatment ISO RGD PMID:23404339 PMID:26699876 PMID:23979166 RGD:10053670, RGD:13782283, RGD:13209143 NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
JBrowse link
G Casp8 caspase 8 severity ISO RGD PMID:20732338 RGD:10053708 NCBI chr 1:58,834,398...58,886,662
Ensembl chr 1:58,834,533...58,886,662
JBrowse link
G Casp9 caspase 9 treatment
severity
ISO
IDA
RGD PMID:17297389 PMID:26699876 PMID:20732338 PMID:20012353 RGD:2315933, RGD:13782283, RGD:10053708, RGD:2315928 NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
JBrowse link
G Cav1 caveolin 1, caveolae protein onset
treatment
IAGP
ISO
IEP
protein:decreased expression:mammary gland RGD PMID:15355971 PMID:15334058 PMID:9685399 RGD:2289106, RGD:8661780, RGD:2289100 NCBI chr 6:17,306,287...17,341,327
Ensembl chr 6:17,306,334...17,341,451
JBrowse link
G Ccna2 cyclin A2 IEP protein:increased expression:mammary gland RGD PMID:10713672 RGD:2293347 NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
JBrowse link
G Ccnb1 cyclin B1 IEP RGD PMID:11146550 RGD:2315939 NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
JBrowse link
G Ccnd1 cyclin D1 IMP
ISO
mRNA, protein:increased expression:mammary gland (rat)
mRNA:increased expression:mammary gland (rat)
CTD Direct Evidence: marker/mechanism
protein:decreased expression:mammary gland
CTD
RGD
PMID:12376462 PMID:14522882 PMID:16316942 PMID:17440082 PMID:12376462 More... RGD:2296037, RGD:2292404, RGD:2306898, RGD:2289336, RGD:2289337 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Ccnd3 cyclin D3 ISO
IMP
mRNA, protein:increased expression:mammary gland RGD PMID:16311245 PMID:12853979 RGD:2316020, RGD:2316015 NCBI chr17:47,815,976...47,910,614
Ensembl chr17:47,815,976...47,910,616
JBrowse link
G Ccne1 cyclin E1 ISO protein:decreased expression:mammary gland RGD PMID:12649181 PMID:12602925 RGD:2289336, RGD:2289337 NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
JBrowse link
G Ccnh cyclin H ISO mRNA:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:12606953 PMID:12606953 RGD:9590264 NCBI chr13:85,337,504...85,361,850
Ensembl chr13:85,337,527...85,371,588
JBrowse link
G Ccr3 chemokine (C-C motif) receptor 3 IEP RGD PMID:21621198 RGD:6893427 NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
JBrowse link
G Ccr5 chemokine (C-C motif) receptor 5 ISO RGD PMID:14597737 PMID:22637726 RGD:8551810, RGD:8551813 NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
JBrowse link
G Cd274 CD274 antigen treatment ISO RGD PMID:29043842 RGD:40886270 NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
JBrowse link
G Cd40 CD40 antigen IEP RGD PMID:21137078 RGD:8547744 NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
JBrowse link
G Cd44 CD44 antigen ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
JBrowse link
G Cdc25a cell division cycle 25A ISO
IMP
RGD PMID:17283130 PMID:16951165 PMID:17638870 RGD:2764000, RGD:2771824, RGD:2754551 NCBI chr 9:109,704,545...109,722,963
Ensembl chr 9:109,704,647...109,722,963
JBrowse link
G Cdc42 cell division cycle 42 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 4:137,047,007...137,085,070
Ensembl chr 4:137,047,007...137,085,031
JBrowse link
G Cdh1 cadherin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
JBrowse link
G Cdh13 cadherin 13 severity IAGP RGD PMID:18316604 RGD:2293540 NCBI chr 8:119,010,150...120,051,668
Ensembl chr 8:119,010,472...120,051,660
JBrowse link
G Cdk2 cyclin-dependent kinase 2 IEP RGD PMID:16924466 RGD:2293558 NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
JBrowse link
G Cdk4 cyclin-dependent kinase 4 susceptibility ISO
IAGP
protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:12376462 PMID:14522882 PMID:25221644 PMID:14522882 PMID:16413469 RGD:2293581, RGD:2293577 NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
JBrowse link
G Cdk6 cyclin-dependent kinase 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25221644 NCBI chr 5:3,391,004...3,581,008
Ensembl chr 5:3,391,485...3,581,008
JBrowse link
G Cdkl2 cyclin-dependent kinase-like 2 (CDC2-related kinase) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25333262 NCBI chr 5:92,153,933...92,198,479
Ensembl chr 5:92,153,933...92,191,742
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B treatment ISO protein:increased expression:mammary gland RGD PMID:15844214 PMID:22651929 RGD:2293626, RGD:10045559 NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
JBrowse link
G Cdkn2a cyclin dependent kinase inhibitor 2A disease_progression IAGP
ISO
RGD PMID:18060046 PMID:20681787 RGD:2289674, RGD:8552689 NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
JBrowse link
G Cds1 CDP-diacylglycerol synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 5:101,912,996...101,971,724
Ensembl chr 5:101,912,996...101,971,724
JBrowse link
G Clu clusterin disease_progression ISO RGD PMID:23099883 RGD:8699504 NCBI chr14:66,205,932...66,218,997
Ensembl chr14:66,205,932...66,218,996
JBrowse link
G Cnn3 calponin 3, acidic ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 3:121,220,190...121,251,854
Ensembl chr 3:121,220,146...121,251,856
JBrowse link
G Col18a1 collagen, type XVIII, alpha 1 severity ISO RGD PMID:10766159 RGD:70690 NCBI chr10:76,888,013...77,002,391
Ensembl chr10:76,888,012...77,002,382
JBrowse link
G Col5a1 collagen, type V, alpha 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526
JBrowse link
G Csf1 colony stimulating factor 1 (macrophage) ISO RGD PMID:15205327 RGD:2293710 NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
JBrowse link
G Csn2 casein beta ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:9879772 PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr 5:87,840,478...87,847,288
Ensembl chr 5:87,840,483...87,847,489
JBrowse link
G Csn3 casein kappa ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr 5:88,073,438...88,080,409
Ensembl chr 5:88,073,438...88,080,524
JBrowse link
G Csnk2a1 casein kinase 2, alpha 1 polypeptide ISO
IMP
RGD PMID:11827167 PMID:11827167 RGD:727632, RGD:727632 NCBI chr 2:152,067,851...152,123,772
Ensembl chr 2:152,068,759...152,123,772
JBrowse link
G Ctnnb1 catenin (cadherin associated protein), beta 1 IAGP
IEP
DNA:missense mutations: :p.S33Y, p.S45F
protein:increased expression:mammary gland
RGD PMID:18060046 PMID:17510243 RGD:2289674, RGD:2289816 NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
JBrowse link
G Dbi diazepam binding inhibitor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:120,041,010...120,048,826
Ensembl chr 1:120,041,010...120,048,808
JBrowse link
G Ddr1 discoidin domain receptor family, member 1 ISO
IMP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:21283680 PMID:29298894 RGD:151347446 NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
JBrowse link
G Des desmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:75,336,936...75,345,223
Ensembl chr 1:75,336,973...75,345,223
JBrowse link
G Dio1 deiodinase, iodothyronine, type I ISO RGD PMID:11765219 RGD:727335 NCBI chr 4:107,148,662...107,164,365
Ensembl chr 4:107,148,662...107,164,366
JBrowse link
G Dnmt3b DNA methyltransferase 3B treatment ISO RGD PMID:24447120 RGD:9588304 NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
JBrowse link
G Dusp1 dual specificity phosphatase 1 treatment ISO RGD PMID:20837666 RGD:5129167 NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102
JBrowse link
G Dusp6 dual specificity phosphatase 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr10:99,098,676...99,103,351
Ensembl chr10:99,099,093...99,103,351
JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 9:78,385,735...78,389,006
Ensembl chr 9:78,385,731...78,396,433
JBrowse link
G Efemp1 epidermal growth factor-containing fibulin-like extracellular matrix protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr11:28,803,154...28,876,743
Ensembl chr11:28,803,204...28,876,743
JBrowse link
G Egfr epidermal growth factor receptor ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:2523869 PMID:8603490 PMID:17203220 RGD:2289979 NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
JBrowse link
G Eif5a eukaryotic translation initiation factor 5A ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr11:69,807,538...69,812,784
Ensembl chr11:69,807,540...69,812,784
JBrowse link
G Eno1 enolase 1, alpha non-neuron ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336
JBrowse link
G Epcam epithelial cell adhesion molecule ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr17:87,943,407...87,958,555
Ensembl chr17:87,943,407...87,958,557
JBrowse link
G Ephx1 epoxide hydrolase 1, microsomal ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
JBrowse link
G Epo erythropoietin treatment ISO RGD PMID:12118093 RGD:11041669 NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
JBrowse link
G Epor erythropoietin receptor treatment ISO RGD PMID:12118093 RGD:11041669 NCBI chr 9:21,870,193...21,874,915
Ensembl chr 9:21,870,193...21,874,802
JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 ISO Androgen-dependent
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:8603490 PMID:25221644 PMID:17203220 PMID:12150826 PMID:1913683 RGD:2289979, RGD:6482679, RGD:2289920 NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 ISO RGD PMID:17203220 RGD:2289979 NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521
JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 ISO RGD PMID:17203220 RGD:2289979 NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218
JBrowse link
G Esr1 estrogen receptor 1 (alpha) susceptibility IAGP
ISO
IMP
CTD Direct Evidence: marker/mechanism
protein:increased expression:epithelial cell, nucleus
CTD
RGD
PMID:15637090 PMID:18055862 PMID:11759285 PMID:15637090 RGD:2290019, RGD:8553057, RGD:8552983 NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
JBrowse link
G Esr2 estrogen receptor 2 (beta) treatment ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:epithelial cell, nucleus
CTD
RGD
PMID:15637090 PMID:24078029 PMID:15637090 RGD:7364911, RGD:8552983 NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
JBrowse link
G Ezr ezrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr17:7,005,530...7,050,179
Ensembl chr17:7,005,440...7,050,183
JBrowse link
G F11r F11 receptor ISO RGD PMID:22120722 RGD:7488922 NCBI chr 1:171,265,129...171,292,161
Ensembl chr 1:171,265,103...171,292,171
JBrowse link
G Fabp4 fatty acid binding protein 4, adipocyte ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 3:10,269,402...10,273,676
Ensembl chr 3:10,269,148...10,273,636
JBrowse link
G Fas Fas (TNF receptor superfamily member 6) IMP RGD PMID:18094967 RGD:2290047 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
JBrowse link
G Fbxo10 F-box protein 10 ISO RGD PMID:17404222 RGD:1601189 NCBI chr 4:45,034,248...45,084,604
Ensembl chr 4:45,034,247...45,084,604
JBrowse link
G Fgf10 fibroblast growth factor 10 ISO mRNA:increased expression:mammary gland RGD PMID:18421211 RGD:2292665 NCBI chr13:118,851,235...118,929,109
Ensembl chr13:118,806,327...118,928,651
JBrowse link
G Fgf7 fibroblast growth factor 7 IMP RGD PMID:9000125 RGD:2301094 NCBI chr 2:125,876,578...125,933,105
Ensembl chr 2:125,876,578...125,933,105
JBrowse link
G Fgf8 fibroblast growth factor 8 IMP RGD PMID:9840935 RGD:2301098 NCBI chr19:45,724,930...45,731,506
Ensembl chr19:45,725,237...45,731,354
JBrowse link
G Flt3 FMS-like tyrosine kinase 3 IMP RGD PMID:10498246 RGD:2302211 NCBI chr 5:147,267,551...147,337,299
Ensembl chr 5:147,267,551...147,337,299
JBrowse link
G Fn1 fibronectin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
JBrowse link
G Frmpd1 FERM and PDZ domain containing 1 ISO RGD PMID:17404222 RGD:1601189 NCBI chr 4:45,183,990...45,285,936
Ensembl chr 4:45,184,875...45,285,936
JBrowse link
G Furin furin (paired basic amino acid cleaving enzyme) ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 7:80,038,942...80,055,188
Ensembl chr 7:80,038,333...80,055,184
JBrowse link
G G0s2 G0/G1 switch gene 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 1:192,954,468...192,955,496
Ensembl chr 1:192,954,469...192,955,525
JBrowse link
G Gata3 GATA binding protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:9,861,889...9,892,762
Ensembl chr 2:9,861,889...9,894,845
JBrowse link
G Gatm glycine amidinotransferase (L-arginine:glycine amidinotransferase) ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:122,424,954...122,441,758
Ensembl chr 2:122,424,948...122,441,784
JBrowse link
G Gda guanine deaminase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr19:21,368,671...21,450,025
Ensembl chr19:21,368,671...21,450,809
JBrowse link
G Ggt1 gamma-glutamyltransferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
JBrowse link
G Gh growth hormone treatment ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:12082019 PMID:15528971 PMID:17584969 PMID:17584969 PMID:6139974 RGD:2315650, RGD:11352806 NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691
JBrowse link
G Glycam1 glycosylation dependent cell adhesion molecule 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr15:103,471,186...103,473,508
Ensembl chr15:103,471,186...103,473,508
JBrowse link
G Gnai2 guanine nucleotide binding protein (G protein), alpha inhibiting 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 9:107,491,324...107,512,617
Ensembl chr 9:107,491,324...107,512,566
JBrowse link
G Gsk3b glycogen synthase kinase 3 beta treatment ISO RGD PMID:28810530 RGD:13792729 NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
JBrowse link
G Gsn gelsolin ISO mRNA:decreased expression RGD PMID:8895730 RGD:1599869 NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
JBrowse link
G Gss glutathione synthetase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:155,405,101...155,434,730
Ensembl chr 2:155,405,101...155,434,730
JBrowse link
G H19 H19, imprinted maternally expressed transcript ISO RGD PMID:15170812 RGD:1642758 NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,131,886
JBrowse link
G H2ax H2A.X variant histone treatment IDA RGD PMID:22384017 RGD:7240549 NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
JBrowse link
G H3f3b H3.3 histone B EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr11:115,912,787...115,921,313
Ensembl chr11:115,912,738...115,918,788
JBrowse link
G Hba-a1 hemoglobin alpha, adult chain 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr11:32,233,672...32,234,486
Ensembl chr11:32,233,511...32,234,465
JBrowse link
G Hif1a hypoxia inducible factor 1, alpha subunit treatment ISO RGD PMID:17280655 RGD:2293194 NCBI chr12:73,948,098...73,994,328
Ensembl chr12:73,948,149...73,994,304
JBrowse link
G Hmox1 heme oxygenase 1 treatment ISO CTD Direct Evidence: therapeutic CTD
RGD
PMID:16319139 PMID:23215791 RGD:10755708 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Hnrnpa1 heterogeneous nuclear ribonucleoprotein A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr15:103,148,370...103,155,125
Ensembl chr15:103,148,859...103,155,119
JBrowse link
G Hnrnpab heterogeneous nuclear ribonucleoprotein A/B ISO CTD Direct Evidence: marker/mechanism CTD PMID:15538050 NCBI chr11:51,490,927...51,497,708
Ensembl chr11:51,490,927...51,497,674
JBrowse link
G Hp haptoglobin treatment ISO RGD PMID:23880232 RGD:11041861 NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
JBrowse link
G Hras Harvey rat sarcoma virus oncogene ISO DNA:mutation: :p.G12E (rat)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:8185828 PMID:11376698 PMID:19652463 RGD:2314834 NCBI chr 7:140,769,847...140,773,938
Ensembl chr 7:140,769,018...140,773,918
JBrowse link
G Id1 inhibitor of DNA binding 1, HLH protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr 2:152,578,171...152,579,330
Ensembl chr 2:152,578,171...152,579,330
JBrowse link
G Id3 inhibitor of DNA binding 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 4:135,871,133...135,872,703
Ensembl chr 4:135,870,808...135,873,066
JBrowse link
G Id4 inhibitor of DNA binding 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14633621 NCBI chr13:48,414,592...48,419,504
Ensembl chr13:48,414,704...48,419,502
JBrowse link
G Igf1 insulin-like growth factor 1 IDA
ISO
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:15217511 PMID:15528971 PMID:17584969 PMID:23342276 RGD:8549490 NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
JBrowse link
G Il10 interleukin 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14999141 NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
JBrowse link
G Il18bp interleukin 18 binding protein ISO mRNA:increased expression:mammary gland RGD PMID:18959458 RGD:2313895 NCBI chr 7:101,664,281...101,669,699
Ensembl chr 7:101,664,092...101,667,897
JBrowse link
G Il1rn interleukin 1 receptor antagonist treatment ISO human protein in a mouse model RGD PMID:21890879 RGD:6771361 NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
JBrowse link
G Il6st interleukin 6 signal transducer ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr13:112,600,604...112,643,394
Ensembl chr13:112,600,604...112,646,620
JBrowse link
G Ilk integrin linked kinase ISO late onset development of tumors in transgenic mice overexpressing human ILK in mammary glands RGD PMID:11704830 RGD:2301733 NCBI chr 7:105,385,797...105,392,132
Ensembl chr 7:105,385,799...105,392,132
JBrowse link
G Insig1 insulin induced gene 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 5:28,276,410...28,283,660
Ensembl chr 5:28,276,361...28,283,660
JBrowse link
G Itgb3 integrin beta 3 ISO protein:increased expression:mammary gland: RGD PMID:22022542 RGD:8693386 NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
JBrowse link
G Kdr kinase insert domain protein receptor ISO RGD PMID:15170218 PMID:19888452 RGD:2291936, RGD:5684399 NCBI chr 5:76,093,487...76,139,885
Ensembl chr 5:76,093,487...76,139,118
JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase ISO DNA:mutation (rat) RGD PMID:18445266 RGD:2302172 NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382
JBrowse link
G Kitl kit ligand ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
JBrowse link
G Krt5 keratin 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr15:101,615,504...101,621,340
Ensembl chr15:101,615,505...101,621,333
JBrowse link
G Krt7 keratin 7 ISO RGD PMID:8570173 RGD:2317439 NCBI chr15:101,310,284...101,325,687
Ensembl chr15:101,308,924...101,328,194
JBrowse link
G Krt71 keratin 71 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr15:101,642,384...101,651,532
Ensembl chr15:101,642,384...101,651,544
JBrowse link
G Lep leptin treatment ISO RGD PMID:22246620 RGD:8694468 NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
JBrowse link
G Lgals7 lectin, galactose binding, soluble 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:28,563,221...28,565,710
Ensembl chr 7:28,563,278...28,565,709
JBrowse link
G Lhcgr luteinizing hormone/choriogonadotropin receptor ISO mRNA:splice variant (rat) RGD PMID:15044717 RGD:2302177 NCBI chr17:89,023,812...89,099,487
Ensembl chr17:89,023,909...89,099,418
JBrowse link
G Lin7a lin-7 homolog A, crumbs cell polarity complex component ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr10:107,107,410...107,261,007
Ensembl chr10:107,107,547...107,257,335
JBrowse link
G Lnpep leucyl/cystinyl aminopeptidase ISO protein:increased expression:serum
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16619500 PMID:16619500 RGD:1582109 NCBI chr17:17,747,985...17,846,303
Ensembl chr17:17,741,672...17,845,312
JBrowse link
G Lpl lipoprotein lipase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
JBrowse link
G Lsr lipolysis stimulated lipoprotein receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 7:30,657,195...30,672,894
Ensembl chr 7:30,657,195...30,672,889
JBrowse link
G Map2k3 mitogen-activated protein kinase kinase 3 ISO RGD PMID:24233520 RGD:7495808 NCBI chr11:60,822,880...60,843,637
Ensembl chr11:60,822,859...60,843,637
JBrowse link
G Map2k7 mitogen-activated protein kinase kinase 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21317887 NCBI chr 8:4,288,740...4,297,897
Ensembl chr 8:4,288,740...4,297,897
Ensembl chr 8:4,288,740...4,297,897
JBrowse link
G Mapk1 mitogen-activated protein kinase 1 treatment ISO RGD PMID:29435821 RGD:13800872 NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
JBrowse link
G Mapk3 mitogen-activated protein kinase 3 treatment ISO RGD PMID:29435821 RGD:13800872 NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
JBrowse link
G Mdh2 malate dehydrogenase 2, NAD (mitochondrial) ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 5:135,807,503...135,819,240
Ensembl chr 5:135,807,334...135,819,252
JBrowse link
G Mgp matrix Gla protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 6:136,849,433...136,852,821
Ensembl chr 6:136,849,433...136,852,821
JBrowse link
G Mif macrophage migration inhibitory factor (glycosylation-inhibiting factor) ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
JBrowse link
G Mir155 microRNA 155 ISO RGD PMID:20354188 PMID:29643534 RGD:21079418, RGD:21403681 NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
JBrowse link
G Mmp13 matrix metallopeptidase 13 severity IEP RGD PMID:18698413 RGD:2306081 NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
JBrowse link
G Mmp15 matrix metallopeptidase 15 IEP mRNA:increased expression:mammary gland RGD PMID:15895410 RGD:2314949 NCBI chr 8:96,078,924...96,100,921
Ensembl chr 8:96,078,896...96,101,708
JBrowse link
G Mmp1a matrix metallopeptidase 1a (interstitial collagenase) treatment ISO RGD PMID:19622769 RGD:8549722 NCBI chr 9:7,464,141...7,476,870
Ensembl chr 9:7,464,141...7,476,857
JBrowse link
G Mmp1b matrix metallopeptidase 1b (interstitial collagenase) treatment ISO RGD PMID:19622769 RGD:8549722 NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
JBrowse link
G Mmp2 matrix metallopeptidase 2 treatment ISO
IDA
protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:28574600 PMID:19725228 PMID:23359979 RGD:2325823, RGD:8657038 NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
JBrowse link
G Mmp3 matrix metallopeptidase 3 ISO RGD PMID:10428026 RGD:8662909 NCBI chr 9:7,445,822...7,455,975
Ensembl chr 9:7,445,822...7,455,975
JBrowse link
G Mmp7 matrix metallopeptidase 7 onset IMP RGD PMID:9850086 RGD:9685350 NCBI chr 9:7,692,091...7,699,586
Ensembl chr 9:7,692,091...7,699,586
JBrowse link
G Mmp9 matrix metallopeptidase 9 treatment ISO
IEP
mRNA, protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:21283680 PMID:19725228 PMID:23359979 RGD:2325823, RGD:8657038 NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
JBrowse link
G Mpzl1 myelin protein zero-like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 1:165,419,745...165,462,144
Ensembl chr 1:165,419,809...165,462,107
JBrowse link
G Mrc2 mannose receptor, C type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr11:105,183,440...105,241,971
Ensembl chr11:105,183,469...105,241,965
JBrowse link
G mt-Co1 cytochrome c oxidase I, mitochondrial ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
JBrowse link
G Mtor mechanistic target of rapamycin kinase ISO RGD PMID:22349822 RGD:10040957 NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
JBrowse link
G Muc1 mucin 1, transmembrane treatment ISO RGD PMID:23015160 RGD:7349374 NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
JBrowse link
G Myc myelocytomatosis oncogene treatment IEP RGD PMID:22384017 RGD:7240549 NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
JBrowse link
G Ncoa1 nuclear receptor coactivator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21080969 NCBI chr12:4,297,362...4,569,452
Ensembl chr12:4,297,362...4,527,182
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 treatment ISO RGD PMID:22072621 RGD:10412719 NCBI chr 2:75,505,857...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Notch4 notch 4 ISO RGD PMID:15531924 RGD:2299154 NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477
JBrowse link
G Nsmf NMDA receptor synaptonuclear signaling and neuronal migration factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:24,944,370...24,952,893
Ensembl chr 2:24,944,367...24,952,893
JBrowse link
G Nudt1 nudix (nucleoside diphosphate linked moiety X)-type motif 1 ISO mRNA:increased expression:mammary gland RGD PMID:12036445 RGD:724605 NCBI chr 5:140,307,377...140,323,892
Ensembl chr 5:140,307,411...140,323,892
JBrowse link
G Oxt oxytocin ISO CTD Direct Evidence: therapeutic CTD PMID:8647655 PMID:15089975 NCBI chr 2:130,416,432...130,418,974
Ensembl chr 2:130,418,093...130,418,974
JBrowse link
G Padi4 peptidyl arginine deiminase, type IV ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 4:140,472,819...140,501,514
Ensembl chr 4:140,473,176...140,501,547
JBrowse link
G Pak4 p21 (RAC1) activated kinase 4 ISO RGD PMID:20697354 RGD:7775027 NCBI chr 7:28,258,244...28,297,609
Ensembl chr 7:28,258,244...28,297,610
JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 treatment ISO RGD PMID:23404339 RGD:10053670 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
JBrowse link
G Pcna proliferating cell nuclear antigen ISO mRNA,protein:increased expression:mammary gland: RGD PMID:2567593 RGD:10448972 NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
JBrowse link
G Pcp4 Purkinje cell protein 4 ISO mRNA,protein:increased expression:cytoplasm: RGD PMID:19480007 RGD:9850273 NCBI chr16:96,268,806...96,326,993
Ensembl chr16:96,268,806...96,326,993
JBrowse link
G Pdgfa platelet derived growth factor, alpha ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 PMID:16316942 PMID:12376462 PMID:16316942 RGD:2292404, RGD:2306898 NCBI chr 5:138,961,769...138,986,336
Ensembl chr 5:138,961,769...138,983,125
JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 5:117,420,716...117,425,629
Ensembl chr 5:117,420,719...117,425,690
JBrowse link
G Pgam1 phosphoglycerate mutase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr19:41,900,310...41,907,104
Ensembl chr19:41,900,362...41,907,099
JBrowse link
G Pgr progesterone receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:15637090 NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
JBrowse link
G Phb prohibitin ISO mRNA, protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599
JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725
JBrowse link
G Pin1 peptidyl-prolyl cis/trans isomerase, NIMA-interacting 1 ISO RGD PMID:22064478 RGD:8693420 NCBI chr 9:20,563,335...20,575,008
Ensembl chr 9:20,563,391...20,577,880
JBrowse link
G Pkm pyruvate kinase, muscle ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 9:59,563,859...59,586,655
Ensembl chr 9:59,563,651...59,586,658
JBrowse link
G Plau plasminogen activator, urokinase disease_progression ISO RGD PMID:18052026 RGD:6484140 NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
JBrowse link
G Plk2 polo like kinase 2 ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr13:110,531,578...110,537,378
Ensembl chr13:110,531,580...110,537,378
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:11137312 NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
JBrowse link
G Prdx2 peroxiredoxin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 8:85,696,251...85,701,440
Ensembl chr 8:85,696,216...85,701,463
JBrowse link
G Prl prolactin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
JBrowse link
G Prlr prolactin receptor ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr15:10,177,324...10,349,276
Ensembl chr15:10,177,324...10,349,266
JBrowse link
G Psma4 proteasome subunit alpha 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 9:54,858,065...54,865,318
Ensembl chr 9:54,858,074...54,865,314
JBrowse link
G Psme1 proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr14:55,815,951...55,818,984
Ensembl chr14:55,815,580...55,818,986
JBrowse link
G Ptbp1 polypyrimidine tract binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr10:79,690,266...79,700,269
Ensembl chr10:79,690,261...79,700,605
JBrowse link
G Pten phosphatase and tensin homolog onset IAGP RGD PMID:18381417 RGD:2292496 NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
JBrowse link
G Ptger1 prostaglandin E receptor 1 (subtype EP1) ISO CTD Direct Evidence: marker/mechanism CTD PMID:11751431 NCBI chr 8:84,393,171...84,399,385
Ensembl chr 8:84,393,307...84,399,382
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 ISO
IMP
mRNA:increased expression:breast RGD PMID:18279516 PMID:21623034 PMID:18676768 RGD:2300130, RGD:5135030, RGD:2300118 NCBI chr 1:149,975,782...149,983,985
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Ptk2 PTK2 protein tyrosine kinase 2 disease_progression IAGP
ISO
CTD Direct Evidence: therapeutic CTD
RGD
PMID:24809783 PMID:18056629 PMID:15930288 RGD:2292554, RGD:2292560 NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
JBrowse link
G Ptn pleiotrophin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 6:36,691,859...36,787,114
Ensembl chr 6:36,691,864...36,787,155
JBrowse link
G Ptprb protein tyrosine phosphatase, receptor type, B treatment IMP RGD PMID:23899555 RGD:151660352 NCBI chr10:116,111,407...116,225,443
Ensembl chr10:116,111,428...116,225,440
JBrowse link
G Ran RAN, member RAS oncogene family ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 5:129,097,220...129,101,386
Ensembl chr 5:129,097,133...129,101,387
JBrowse link
G Rasa1 RAS p21 protein activator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr13:85,362,818...85,437,605
Ensembl chr13:85,362,899...85,437,249
JBrowse link
G Rasgrf2 RAS protein-specific guanine nucleotide-releasing factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr13:92,028,526...92,268,584
Ensembl chr13:92,028,519...92,268,164
JBrowse link
G Rb1 RB transcriptional corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14522882 NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
JBrowse link
G Rbp1 retinol binding protein 1, cellular ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr 9:98,305,014...98,328,604
Ensembl chr 9:98,305,014...98,328,628
JBrowse link
G Rbp4 retinol binding protein 4, plasma ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr19:38,105,068...38,113,769
Ensembl chr19:38,105,077...38,113,729
JBrowse link
G Rcn1 reticulocalbin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:105,216,293...105,229,664
Ensembl chr 2:105,216,636...105,229,664
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) IEP protein:decreased expression:peritoneal macrophage RGD PMID:16288051 RGD:2298764 NCBI chr19:5,687,569...5,698,162
Ensembl chr19:5,687,511...5,698,158
JBrowse link
G Relb avian reticuloendotheliosis viral (v-rel) oncogene related B IEP RGD PMID:16260626 RGD:7777148 NCBI chr 7:19,340,142...19,363,363
Ensembl chr 7:19,340,142...19,363,363
JBrowse link
G Rnpep arginyl aminopeptidase (aminopeptidase B) ISO protein:increased expression:serum
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16619500 PMID:16619500 RGD:1582109 NCBI chr 1:135,190,437...135,212,222
Ensembl chr 1:135,190,450...135,211,822
JBrowse link
G Rpl3 ribosomal protein L3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr15:79,961,982...79,967,607
Ensembl chr15:79,961,992...79,976,069
JBrowse link
G Rpl6 ribosomal protein L6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 5:121,342,564...121,347,304
Ensembl chr 5:121,342,544...121,347,304
JBrowse link
G Rps14 ribosomal protein S14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr18:60,907,668...60,911,618
Ensembl chr18:60,880,170...60,911,618
JBrowse link
G Runx1 runt related transcription factor 1 ISO mRNA:increased expression:mammary gland RGD PMID:29435983 RGD:126779584 NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037
JBrowse link
G Rxra retinoid X receptor alpha ISO RGD PMID:16344269 RGD:1643109 NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
JBrowse link
G S100a6 S100 calcium binding protein A6 (calcyclin) ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 3:90,520,201...90,521,721
Ensembl chr 3:90,520,189...90,531,488
JBrowse link
G S1pr1 sphingosine-1-phosphate receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 3:115,504,082...115,508,704
Ensembl chr 3:115,504,082...115,508,721
JBrowse link
G Scarb1 scavenger receptor class B, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 5:125,354,151...125,418,158
Ensembl chr 5:125,354,151...125,418,158
JBrowse link
G Scd2 stearoyl-Coenzyme A desaturase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303
JBrowse link
G Selenop selenoprotein P ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr15:3,300,249...3,309,992
Ensembl chr15:3,298,029...3,309,990
JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr10:21,758,083...21,875,802
Ensembl chr10:21,758,083...21,875,802
JBrowse link
G Slc12a2 solute carrier family 12, member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr18:58,011,505...58,079,893
Ensembl chr18:58,011,750...58,079,893
JBrowse link
G Slc25a10 solute carrier family 25 (mitochondrial carrier, dicarboxylate transporter), member 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr11:120,382,663...120,391,987
Ensembl chr11:120,382,666...120,390,013
JBrowse link
G Sncg synuclein, gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr14:34,092,231...34,096,626
Ensembl chr14:34,092,231...34,096,746
JBrowse link
G Snrpd3 small nuclear ribonucleoprotein D3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr10:75,353,876...75,371,274
Ensembl chr10:75,353,385...75,373,215
JBrowse link
G Socs1 suppressor of cytokine signaling 1 IEP
ISO
mRNA:increased expression:mammary gland RGD PMID:18381452 PMID:20354188 RGD:2298899, RGD:21079418 NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
JBrowse link
G Socs3 suppressor of cytokine signaling 3 IEP mRNA:increased expression:mammary gland RGD PMID:18381452 RGD:2298899 NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial ISO CTD Direct Evidence: marker/mechanism CTD PMID:23964924 NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
JBrowse link
G Sox9 SRY (sex determining region Y)-box 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr11:112,673,036...112,678,583
Ensembl chr11:112,673,050...112,678,586
JBrowse link
G Spint2 serine protease inhibitor, Kunitz type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:28,955,755...28,981,484
Ensembl chr 7:28,955,748...28,981,337
JBrowse link
G Spp1 secreted phosphoprotein 1 ISO CTD Direct Evidence: therapeutic CTD PMID:15318939 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
JBrowse link
G Srsf2 serine and arginine-rich splicing factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr11:116,740,723...116,744,511
Ensembl chr11:116,740,727...116,743,920
JBrowse link
G Stat1 signal transducer and activator of transcription 1 IEP RGD PMID:11325527 RGD:2291895 NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
JBrowse link
G Stat3 signal transducer and activator of transcription 3 IDA
ISO
mRNA:increased expression:mammary gland (rat)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16316942 PMID:17483332 PMID:16316942 RGD:2291914, RGD:2306898 NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
JBrowse link
G Stat5a signal transducer and activator of transcription 5A susceptibility ISO
IMP
IAGP
protein:altered localization:nucleus
mRNA, protein:increased expression:mammary gland (rat)
mRNA:increased expression:mammary gland (rat)
CTD Direct Evidence: marker/mechanism
protein:increased tyrosine phosphorylation:mammary gland
CTD
RGD
PMID:12376462 PMID:15609129 PMID:16316942 PMID:15609129 PMID:20181624 More... RGD:2291932, RGD:151665819, RGD:2292404, RGD:2306898, RGD:2291927, RGD:2298539 NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995
JBrowse link
G Stat6 signal transducer and activator of transcription 6 IDA DNA:gene knockout::Balb/C-derived Stat6(-/-) mice resistant to growth of implanted Balb/C mammary tumors RGD PMID:11086031 RGD:2298563 NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826
JBrowse link
G Stc2 stanniocalcin 2 ISO mRNA:increased expression:mammary gland RGD PMID:18959458 RGD:2313895 NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074
JBrowse link
G Stmn1 stathmin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 4:134,195,631...134,201,154
Ensembl chr 4:134,195,631...134,201,154
JBrowse link
G Tdg thymine DNA glycosylase IEP mRNA:increased expression:mammary gland tumor (mouse) RGD PMID:9794235 RGD:2317355 NCBI chr10:82,465,649...82,486,633
Ensembl chr10:82,465,662...82,486,633
JBrowse link
G Terc telomerase RNA component IEP RNA:increased expression:mammary gland RGD PMID:9857231 RGD:2291975 NCBI chr 3:96,321,753...96,322,149
Ensembl chr 3:96,321,753...96,322,149
JBrowse link
G Tff1 trefoil factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251
JBrowse link
G Tgfa transforming growth factor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:8603490 NCBI chr 6:86,172,020...86,252,726
Ensembl chr 6:86,172,205...86,252,701
JBrowse link
G Tgfb1 transforming growth factor, beta 1 IMP RGD PMID:8466857 RGD:7394797 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
JBrowse link
G Tgfbr1 transforming growth factor, beta receptor I ISO RGD PMID:12808151 RGD:737735 NCBI chr 4:47,353,222...47,414,926
Ensembl chr 4:47,353,222...47,414,931
JBrowse link
G Tgfbr2 transforming growth factor, beta receptor II ISO RGD PMID:12808151 RGD:737735 NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428
JBrowse link
G Thbs1 thrombospondin 1 ISO mRNA:increased expression:mammary gland RGD PMID:15459484 RGD:1626167 NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
JBrowse link
G Thrsp thyroid hormone responsive ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:97,062,140...97,066,757
Ensembl chr 7:97,062,145...97,066,937
JBrowse link
G Tkt transketolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr14:30,271,088...30,296,681
Ensembl chr14:30,270,316...30,296,677
JBrowse link
G Tle4 transducin-like enhancer of split 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr19:14,425,436...14,575,547
Ensembl chr19:14,425,514...14,575,415
JBrowse link
G Tnf tumor necrosis factor IMP RGD PMID:19755514 RGD:7401185 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Tnfrsf10b tumor necrosis factor receptor superfamily, member 10b IMP RGD PMID:17671220 RGD:2290495 NCBI chr14:70,004,921...70,021,860
Ensembl chr14:70,004,921...70,021,860
JBrowse link
G Tnfsf10 tumor necrosis factor (ligand) superfamily, member 10 ISO CTD Direct Evidence: therapeutic CTD PMID:21252285 NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
JBrowse link
G Tpm3 tropomyosin 3, gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 3:89,979,958...90,008,209
Ensembl chr 3:89,979,956...90,008,209
JBrowse link
G Trf transferrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:9879772 PMID:16316942 NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
JBrowse link
G Trp53 transformation related protein 53 disease_progression ISO
EXP
IAGP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:24809783 PMID:17470299 PMID:18092324 RGD:2290577, RGD:2290539 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Trps1 transcriptional repressor GATA binding 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr15:50,518,149...50,754,027
Ensembl chr15:50,518,148...50,753,859
JBrowse link
G Tsc22d1 TSC22 domain family, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr14:76,652,401...76,745,205
Ensembl chr14:76,652,401...76,745,205
JBrowse link
G Tubb2b tubulin, beta 2B class IIB ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr13:34,310,991...34,314,337
Ensembl chr13:34,310,731...34,314,449
JBrowse link
G Txnip thioredoxin interacting protein severity ISO mRNA:decreased expression:mammary gland RGD PMID:15170812 RGD:1642758 NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
JBrowse link
G Tyms thymidylate synthase ISO RGD PMID:9635926 RGD:2315839 NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
JBrowse link
G Ube2i ubiquitin-conjugating enzyme E2I ISO MCF-7 human breast cancer cell tumors grown in nude mice
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16316942 PMID:15735760 RGD:2301345 NCBI chr17:25,479,484...25,494,965
Ensembl chr17:25,480,890...25,493,596
JBrowse link
G Ucp2 uncoupling protein 2 (mitochondrial, proton carrier) ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:100,142,544...100,148,836
Ensembl chr 7:100,142,544...100,151,227
JBrowse link
G Vamp8 vesicle-associated membrane protein 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 6:72,362,204...72,367,650
Ensembl chr 6:72,362,206...72,367,686
JBrowse link
G Vdr vitamin D (1,25-dihydroxyvitamin D3) receptor IMP RGD PMID:15333467 RGD:8158073 NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
JBrowse link
G Vegfa vascular endothelial growth factor A treatment ISO human protein in a mouse model RGD PMID:21890879 RGD:6771361 NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
JBrowse link
G Wap whey acidic protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr11:6,585,483...6,588,654
Ensembl chr11:6,585,482...6,588,637
JBrowse link
G Wnt1 wingless-type MMTV integration site family, member 1 IDA in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr15:98,687,738...98,691,711
Ensembl chr15:98,687,738...98,691,718
JBrowse link
G Wnt2 wingless-type MMTV integration site family, member 2 ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr 6:17,988,939...18,032,771
Ensembl chr 6:17,988,939...18,030,584
JBrowse link
G Wnt3 wingless-type MMTV integration site family, member 3 IDA in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 RGD:2298848 NCBI chr11:103,665,001...103,708,847
Ensembl chr11:103,664,976...103,708,783
JBrowse link
G Wnt3a wingless-type MMTV integration site family, member 3A IDA in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr11:59,138,862...59,181,577
Ensembl chr11:59,138,859...59,181,578
JBrowse link
G Wnt5b wingless-type MMTV integration site family, member 5B no_association IDA in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr 6:119,409,492...119,521,880
Ensembl chr 6:119,409,492...119,521,308
JBrowse link
G Wnt6 wingless-type MMTV integration site family, member 6 no_association IDA in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr 1:74,793,499...74,824,481
Ensembl chr 1:74,811,051...74,824,481
JBrowse link
G Wnt7a wingless-type MMTV integration site family, member 7A IDA in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr 6:91,340,963...91,388,335
Ensembl chr 6:91,340,963...91,388,345
JBrowse link
G Wnt7b wingless-type MMTV integration site family, member 7B no_association IDA in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr15:85,419,638...85,466,022
Ensembl chr15:85,419,638...85,466,674
JBrowse link
G Xdh xanthine dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr17:74,190,890...74,257,369
Ensembl chr17:74,190,890...74,257,191
JBrowse link
G Xiap X-linked inhibitor of apoptosis ISO CTD Direct Evidence: therapeutic CTD PMID:12766084 NCBI chr  X:41,148,483...41,198,541
Ensembl chr  X:41,148,556...41,198,533
JBrowse link
G Xrcc3 X-ray repair complementing defective repair in Chinese hamster cells 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr12:111,769,626...111,780,326
Ensembl chr12:111,769,626...111,780,307
JBrowse link
G Ywhaz tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr15:36,770,505...36,803,228
Ensembl chr15:36,771,014...36,797,173
JBrowse link
Sarcoma, Yoshida term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Dpyd dihydropyrimidine dehydrogenase treatment ISO RGD PMID:8138551 RGD:11251753 NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 15270
    disease of cellular proliferation 7123
      Experimental Neoplasms 515
        Carcinoma 256, Walker 0
        Carcinoma, Brown-Pearce 0
        Carcinoma, Krebs 2 0
        Carcinoma, Lewis Lung 11
        Ehrlich tumor carcinoma 3
        Experimental Leukemia + 9
        Experimental Liver Neoplasms 166
        Experimental Melanoma 23
        Experimental Sarcoma + 9
        Mammary Neoplasms, Experimental 290
Path 2
Term Annotations click to browse term
  disease 15270
    Animal Diseases 1367
      Animal Disease Models 1318
        Experimental Neoplasms 515
          Carcinoma 256, Walker 0
          Carcinoma, Brown-Pearce 0
          Carcinoma, Krebs 2 0
          Carcinoma, Lewis Lung 11
          Ehrlich tumor carcinoma 3
          Experimental Leukemia + 9
          Experimental Liver Neoplasms 166
          Experimental Melanoma 23
          Experimental Sarcoma + 9
          Mammary Neoplasms, Experimental 290
paths to the root